SPOTLIGHT -
Slideshow
Author(s):
Patients with difficult conditions such as delusional parasitosis tend to resist the notion that a psychiatric problem underlies their symptoms.
April in Review: Updates on the Psychiatric Treatment Pipeline
Blue Light Blockers: A Behavior Therapy for Mania
Transneural Therapeutics: A New Company to Develop Novel Neuroplastogens
Treating ‘Morally Objectionable’ Patients
Cybin Announces Partnership With Osmind to Advance Clinical-Stage Psychiatry Programs
MindMed Begins Phase 3 Emerge Study of MM120 in Patients With Major Depressive Disorder